Adaptimmune Therapeutics PLC (ADAPY) vs Allarity Therapeutics, Inc. (ALLR)
- Adaptimmune Therapeutics PLC ADAPY 0.03 0.00%
- Allarity Therapeutics, Inc. ALLR 0.95 +4.40%
Adaptimmune Therapeutics PLC and Allarity Therapeutics, Inc. are both Biotechnology companies. Adaptimmune Therapeutics PLC and Allarity Therapeutics, Inc. are of similar size ($14.6M and $14.5M). Allarity Therapeutics, Inc. has the higher net margin (0.00% vs −262.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Allarity Therapeutics, Inc. leads on 7 and Adaptimmune Therapeutics PLC on 4.
Valuation
Profitability
| Metric | ADAPY | ALLR | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.81% | 0.00% | 67.24% |
| Operating margin | (427.75%) | 0.00% | 0.00% |
| Net margin | (262.46%) | 0.00% | 0.00% |
| Free cash flow margin | (294.49%) | 0.00% | 0.00% |
| Return on equity | (1,349.52%) | 0.00% | (50.28%) |
| Return on assets | 0.00% | 0.00% | (45.89%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack